Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica

Page 1 of about 1 results

ea0073pep10.2 | Presented ePosters 10: Thyroid | ECE2021

Graves’ disease and concurrent immune thrombocytopenia in a patient with albinism following alemtuzumab treatment for multiple sclerosis: a rare case report

Daraki Vasiliki , Eleni-Konstantina Syntzanaki , Mastorodemos Vasileios , Kontolaimaki Kalliopi , Mytilinaiou Maria , Chrysoulaki Maria , Sfakiotaki Maria , Betsi Grigoria , Xekouki Paraskevi

IntroductionAlemtuzumab is an anti-CD52 antibody, leading to lysis and transient depletion of T and B lymphocytes. Its therapeutic effect is mediated by the alteration in immune repertoire that accompanies subsequent lymphocyte reconstitution. It is mainly used for the treatment of relapsing–remitting multiple sclerosis (RRMS). Common side effects are autoimmune diseases, including thyroid disease (>40%), immune thrombocytopenia (IT...
0 shares

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more